Cohen & Steers, Inc. (CNS) stock
CNSNYSEInvestment AdviceFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 14/307% above fair value
$71.35−0.07 (-0.10%)
Close on Nov 13, 2026Market cap $3.67BP/E 21.9Yield 3.48%
Cohen & Steers EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Cohen & Steers's EPS for the twelve months ending Sep 30, 2026 was $3.26, up 2.2% year over year. For fiscal 2025 it was $2.97, up 0.0% from the year before. Over ten years it grew 7.7% a year on average. The highest annual figure on record is $4.31 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.97 | 0.0% |
| FY2024 | Dec 31, 2024 | $2.97 | +14.2% |
| FY2023 | Dec 31, 2023 | $2.60 | -25.1% |
| FY2022 | Dec 31, 2022 | $3.47 | -19.5% |
| FY2021 | Dec 31, 2021 | $4.31 | +174.5% |
| FY2020 | Dec 31, 2020 | $1.57 | -43.7% |
| FY2019 | Dec 31, 2019 | $2.79 | +16.3% |
| FY2018 | Dec 31, 2018 | $2.40 | +22.4% |
| FY2017 | Dec 31, 2017 | $1.96 | -2.0% |
| FY2016 | Dec 31, 2016 | $2.00 | +41.8% |
| FY2015 | Dec 31, 2015 | $1.41 | -14.5% |
| FY2014 | Dec 31, 2014 | $1.65 | +9.3% |
| FY2013 | Dec 31, 2013 | $1.51 | +1.3% |
| FY2012 | Dec 31, 2012 | $1.49 | +21.1% |
| FY2011 | Dec 31, 2011 | $1.23 | +15.0% |
| FY2010 | Dec 31, 2010 | $1.07 | – |
| FY2009 | Dec 31, 2009 | -$0.04 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.81 | 0.0% |
| Q2 FY2026 | Jun 30, 2026 | $0.95 | +31.9% |
| Q1 FY2026 | Mar 31, 2026 | $0.82 | +6.5% |
| Q4 FY2025 | Dec 31, 2025 | $0.68 | -23.6% |
| Q3 FY2025 | Sep 30, 2025 | $0.81 | +5.2% |
| Q2 FY2025 | Jun 30, 2025 | $0.72 | +14.3% |
| Q1 FY2025 | Mar 31, 2025 | $0.77 | +13.2% |
| Q4 FY2024 | Dec 31, 2024 | $0.89 | +48.3% |
| Q3 FY2024 | Sep 30, 2024 | $0.77 | +18.5% |
| Q2 FY2024 | Jun 30, 2024 | $0.63 | -1.6% |
| Q1 FY2024 | Mar 31, 2024 | $0.68 | -4.2% |
| Q4 FY2023 | Dec 31, 2023 | $0.60 | -9.1% |
| Q3 FY2023 | Sep 30, 2023 | $0.65 | -27.8% |
| Q2 FY2023 | Jun 30, 2023 | $0.64 | -39.6% |
| Q1 FY2023 | Mar 31, 2023 | $0.71 | -16.5% |
| Q4 FY2022 | Dec 31, 2022 | $0.66 | -49.2% |
| Q3 FY2022 | Sep 30, 2022 | $0.90 | -14.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.06 | +11.6% |
| Q1 FY2022 | Mar 31, 2022 | $0.85 | -15.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.30 | – |
| Q3 FY2021 | Sep 30, 2021 | $1.05 | +59.1% |
| Q2 FY2021 | Jun 30, 2021 | $0.95 | +61.0% |
| Q1 FY2021 | Mar 31, 2021 | $1.00 | +138.1% |
| Q4 FY2020 | Dec 31, 2020 | -$0.09 | -112.0% |
| Q3 FY2020 | Sep 30, 2020 | $0.66 | -5.7% |
| Q2 FY2020 | Jun 30, 2020 | $0.59 | -9.2% |
| Q1 FY2020 | Mar 31, 2020 | $0.42 | -38.2% |
| Q4 FY2019 | Dec 31, 2019 | $0.75 | +38.9% |
| Q3 FY2019 | Sep 30, 2019 | $0.70 | +7.7% |
| Q2 FY2019 | Jun 30, 2019 | $0.65 | +3.2% |
| Q1 FY2019 | Mar 31, 2019 | $0.68 | +15.3% |
| Q4 FY2018 | Dec 31, 2018 | $0.54 | +25.6% |
| Q3 FY2018 | Sep 30, 2018 | $0.65 | +22.6% |
| Q2 FY2018 | Jun 30, 2018 | $0.63 | +26.0% |
| Q1 FY2018 | Mar 31, 2018 | $0.59 | +20.4% |
| Q4 FY2017 | Dec 31, 2017 | $0.43 | -23.2% |
| Q3 FY2017 | Sep 30, 2017 | $0.53 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.50 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.49 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.56 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?